Diatrizoate Sodium

Products in Health Canada’s databases that list Diatrizoate Sodium as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products: 20; 1 authorized now
Natural health products: 0; 0 active licences
Notices of Compliance: 7
Products in all: 20

Drug products

Authorized products first.

Name	DIN	Status	Holder	Status since
GASTROGRAFIN (10 %)	02228564	Marketed	Bracco Imaging Canada	Apr 1997
GASTROGRAFIN LIQ (10 %)	01995669	Cancelled Post Market	Squibb Diagnostics, Division Of Bristol-Myers Squibb Canada Inc.	Aug 1997
HYPAQUE ORAL LIQUID - 50G/120ML (50 G)	02180626	Cancelled Post Market	Nycomed Imaging A.S.	Apr 1998
HYPAQUE ORAL LIQUID 50GM/120ML (50 G)	02026902	Cancelled Post Market	Sanofi Canada, Inc.	Jul 1997
HYPAQUE ORAL POWDER (997.4 MG)	02180685	Cancelled Post Market	Ge Healthcare Canada Inc	Jul 2011
HYPAQUE ORAL POWDER 0.9974G/G (997.4 MG)	02026988	Cancelled Post Market	Sanofi Canada, Inc.	Jul 1997
HYPAQUE PWR 100% (100 %)	01905007	Cancelled Post Market	Sterling Winthrop Inc.	Sep 1996
HYPAQUE SODIUM 50% - LIQ IV (50 %)	02180650	Cancelled Post Market	Nycomed Imaging A.S.	Apr 2000
HYPAQUE SODIUM 50% LIQ (50 %)	01902768	Cancelled Post Market	Sterling Winthrop Inc.	Sep 1996
HYPAQUE SODIUM LIQ 50% (50 %)	02017784	Cancelled Post Market	Sanofi Canada, Inc.	Jul 1997
HYPAQUE-M 76% (10 %)	02180677	Cancelled Post Market	Amersham Health Inc.	Jul 2005
HYPAQUE-M 76% LIQ (10 %)	02026996	Cancelled Post Market	Sanofi Canada, Inc.	Jul 1997
HYPAQUE-M LIQ 76% USP (10 %)	01904841	Cancelled Post Market	Sterling Winthrop Inc.	Sep 1996
MD-60 (80 MG)	00571024	Cancelled Post Market	Tyco Healthcare	Jan 2010
MD-76 (100 MG)	00569739	Cancelled Post Market	Tyco Healthcare	Jan 2010
RENOCAL-76 (10 %)	02232998	Cancelled Post Market	Bracco Imaging Canada	Jun 2009
RENOGRAFIN-60 - LIQ IV (8 %)	02228580	Cancelled Post Market	Bracco Imaging Canada	Jun 2003
RENOGRAFIN-60 LIQ (8 %)	01974009	Cancelled Post Market	Squibb Diagnostics, Division Of Bristol-Myers Squibb Canada Inc.	Jul 1998
RENOGRAFIN-76 - LIQ IV (10 %)	02228637	Cancelled Post Market	Bracco Imaging Canada	Jun 2002
RENOGRAFIN-76 LIQ (10 %)	01963929	Cancelled Post Market	Squibb Diagnostics, Division Of Bristol-Myers Squibb Canada Inc.	Jul 1998

Notices of Compliance

Approvals of drug submissions that list it, newest first.

GASTROGRAFINApril 29, 2022 · NOC 28043
GASTROGRAFINDecember 15, 2017 · NOC 20168
GASTROGRAFINAugust 23, 2017 · NOC 19698
HYPAQUE ORAL POWDERMarch 29, 2006 · NOC 7857
MD-60; MD-76August 1, 2002 · NOC 417
HYPAQUE-M 76%June 20, 2002 · NOC 438
HYPAQUE ORAL POWDERJune 6, 2002 · NOC 441